-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-acute-pain.xlsx
May 29, 2025 - Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-acute-pain.xlsx
May 29, 2025 - Results, Function Results, QOL and Satisfaction with Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing … Results, Function Results, QOL and Satisfaction With Pain Relief Results, Persistent Opioid Use and Prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/screening-counseling-interventions-executive-summary.pdf
April 01, 2025 - counseling for moderate-risk and high-
risk behaviors (addressing a positive screen), and appropriate prescribing … collaborative
implementation may have little
to no effect on increase in
guideline-congruent ADHD
prescribing … incorporation and
learning collaborative
implementation approach may
increase guideline-congruent
SSRI prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-brief1-care-coordination.pdf
April 01, 2021 - found not having a usual
provider versus having a usual provider was associated with high-risk opioid prescribing … Safe opioid prescribing for acute noncancer
pain in hospitalized adults: a systematic
review of existing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/topic-brief1-care-coordination.pdf
April 01, 2021 - found not having a usual
provider versus having a usual provider was associated with high-risk opioid prescribing … Safe opioid prescribing for acute noncancer
pain in hospitalized adults: a systematic
review of existing
-
effectivehealthcare.ahrq.gov/health-topics/prescription-drug-abuse
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-databases-methods_research.pdf
May 01, 2008 - In other words, had practitioners followed
the FDA labeling for prescribing cholinesterase inhibitors … Instead, we found that prescribing of these
products in LTC settings was significantly higher among … The comparability of prescribing rates across the settings was also
found despite the different method … The quality of antipsychotic drug prescribing
in nursing homes.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
April 23, 2019 - appropriate to list
anti-sclerostin monoclonal antibody class-specific harms
in Table 3 when the final prescribing … Prescribing
Information, (06/2018).
Cummings SR, Ferrari S, Eastell R et al. … I suggest that the
committee carefully review the FDA-approved Prescribing
Information for each product … Prescribing
Information, (06/2018).
2Miller PD, Bolognese MA, Lew iecki EM et al. … Prescribing
Information, (06/2018).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_research-protocol.pdf
January 27, 2012 - treatment, less than 1 in 10
receives medication as part of his or her treatment, which leads to a prescribing … Very low prescribing rates for these
medications indicate that primary care providers are rarely using … Although primary care providers are proficient at
prescribing a wide variety of medications, they generally … subject recruitment),
interventions (e.g., dose and frequency of administration; type of provider
prescribing … of enrolled
populations; co-occurring disorders of enrolled populations; setting; type of
provider prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-1_research.pdf
February 01, 2009 - Although the precise reasons for DMARD prescribing preferences cannot be assessed in our
study, these
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Pricing,
reimbursement, and prescribing barriers have been the priority for the manufacturers of lorcaserin … The recommended prescribing by the
manufacturer includes an initial low-titration dosage and a mid-titration … The drug has
been classified by DEA as a Schedule IV drug; it became available for prescribing in June … Prescribing a medication and
doing appropriate followup could provide clinicians an opportunity to … Prescribing information for Belviq (lorcaserin
hydrochloride) tablets. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
February 01, 2016 - Clinical Bottom Line (Continued)
ALDH2 = aldehyde dehydrogenase 2
c The prescribing information sheet … Clinicians are advised to refer to the prescribing
information sheet for additional information on adverse
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
December 01, 2013 - abdominal pain.38 Other adverse events associated with azithromycin that could dissuade a physician
from prescribing … KALYDECO (ivacaftor) tablets prescribing
information. [internet]. … Zithromax (azithromycin tablets) and (azithromycin
for oral suspension) prescribing information. … http://www.onlinepharmacycatalog.com/drugs-medications/antibiotics/azithromycin/zithromax-prescribing-information.pdf … http://www.onlinepharmacycatalog.com/drugs-medications/antibiotics/azithromycin/zithromax-prescribing-information.pdf
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
March 28, 2019 - concept is used in multiple
contexts with differing definitions and sometimes is used to
indicate prescribing … I
fear the results of reviews such as this contribute to fear of
prescribing among primary care physicians … consideration in the context of the individual patient
before relying on this comparative harms data to make
prescribing … Resulting
drug-drug interactions and
pharmacokinetic changes must be taken
into consideration when prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_executive.pdf
September 22, 2011 - whether they received therapeutic education from
a third party (health care professional other than the
prescribing
-
effectivehealthcare.ahrq.gov/products/adhd-medicines-risks/abstract
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
March 01, 2012 - What are the provider patterns of prescribing these medications, and
what interventions are used to … support evidence-based decisionmaking
about prescribing? … these medications, and of interventions
used to support evidence-based decisionmaking about prescribing … What are the provider patterns of prescribing these medications, and
what interventions are used to … support evidence-based decisionmaking
about prescribing?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research-2007.pdf
January 01, 2007 - A
randomized, controlled trial of a clinical pharmacist
intervention to improve inappropriate prescribing … or problems)
55.0 5.6
Physician consultation (contact with the patient’s
primary care or other prescribing … Therapy tools and/or education for physicians
(provision of patient-specific reports, physician
prescribing
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
June 01, 2014 - Pricing, reimbursement, and prescribing barriers have been the priority for the manufacturers of
lorcaserin … The
recommended prescribing by the manufacturer includes an initial low-titration dosage and a
mid-titration … Drug Enforcement Administration as a Schedule IV drug; it
became available for prescribing in June … IV drug (i.e., with a low potential for abuse and low risk of dependence); it became
available for prescribing … Prescribing information for Belviq (lorcaserin
hydrochloride) tablets. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
January 01, 2015 - FDA Drug Safety Communication: FDA requires
removal of some prescribing and dispensing restrictions … Highlights of Prescribing Information - Invokana (canagliflozin) tablets, for oral use. 2013
[cited … 2014 July 9]; Available from: https://www.invokanahcp.com/prescribing-
information.pdf.
20. … Highlights of Prescribing Information - Farxiga (dapagliflozin) tablets, for oral use. 2014
[cited … http:www.effectivehealthcare.ahrq.gov
http://www1.astrazeneca
https://www.invokanahcp.com/prescribing